Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-04-08 Sale | 2024-04-09 6:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, HEAD OF COMMERCIAL | 2,568 | $17.87 | $45,890 | 48,844 (Direct) | View |
| 2024-03-27 Sale | 2024-03-27 8:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, HEAD OF COMMERCIAL | 5,140 | $17.9 | $92,006 | 153,316 (Direct) | View |
| 2024-02-26 Sale | 2024-02-27 6:10 pm | ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, HEAD OF COMMERCIAL | 624 | $24.67 | $15,394 | 32,539 (Direct) | View |
| 2024-01-08 Sale | 2024-01-09 6:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, Head of Commercial | 731 | $29.96 | $21,901 | 30,949 (Direct) | View |
| 2023-11-20 Sale | 2023-11-21 6:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, Head of Commercial | 4,960 | $22.64 | $112,294 | 70,045 (Direct) | View |
| 2023-05-17 Sale | 2023-05-19 6:43 pm | ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, Head of Commercial | 14,869 | $22.5 | $334,553 | 73,920 (Direct) | View |
| 2023-05-01 Sale | 2023-05-02 7:04 pm | ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, Head of Commercial | 548 | $21.18 | $11,607 | 9,487 (Direct) | View |
| 2023-04-06 Sale | 2023-04-07 8:44 pm | ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, Head of Commercial | 1,751 | $18.16 | $31,798 | 23,540 (Direct) | View |
| 2023-02-24 Sale | 2023-02-27 9:00 pm | ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, Head of Commercial | 461 | $18.78 | $8,658 | 7,409 (Direct) | View |
| 2023-01-09 Sale | 2023-01-10 8:30 pm | ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, Head of Commercial | 532 | $17.13 | $9,113 | 8,409 (Direct) | View |
| 2022-05-02 Sale | 2022-05-03 8:47 pm | ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, Head of Commercial | 552 | $18.18 | $10,036 | 5,004 (Direct) | View |
| 2022-02-23 Sale | 2022-02-25 5:45 pm | ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, Head of Commercial | 472 | $23.8 | $11,234 | 5,743 (Direct) | View |
| 2022-01-06 Sale | 2022-01-10 6:25 pm | ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, Head of Commercial | 538 | $23.05 | $12,401 | 4,361 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-05 Exercise | 2024-04-09 6:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, HEAD OF COMMERCIAL | 5,024 | $0 | 48,844 (Direct) | View |
| 2024-03-25 Option Award | 2024-03-27 8:00 pm | N/A 2034-03-24 | ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, HEAD OF COMMERCIAL | 127,024 | $0 | 153,316 (Direct) | View |
| 2024-02-23 Exercise | 2024-02-27 6:10 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, HEAD OF COMMERCIAL | 1,107 | $0 | 32,539 (Direct) | View |
| 2024-01-06 Exercise | 2024-01-09 6:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, Head of Commercial | 1,287 | $0 | 30,949 (Direct) | View |
| 2023-11-17 Exercise | 2023-11-21 6:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, Head of Commercial | 9,912 | $0 | 70,045 (Direct) | View |
| 2023-05-17 Exercise | 2023-05-19 6:43 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, Head of Commercial | 29,738 | $0 | 73,920 (Direct) | View |
| 2023-05-01 Option Award | 2023-05-03 9:17 pm | N/A 2033-05-01 | ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, Head of Commercial | 117,195 | $0 | 117,195 (Direct) | View |
| 2023-04-29 Exercise | 2023-05-02 7:04 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, Head of Commercial | 1,567 | $0 | 9,487 (Direct) | View |
| 2023-04-05 Exercise | 2023-04-07 8:44 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, Head of Commercial | 5,024 | $0 | 23,540 (Direct) | View |
| 2023-02-23 Exercise | 2023-02-27 9:00 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, Head of Commercial | 1,107 | $0 | 7,409 (Direct) | View |
| 2022-01-06 Exercise | 2023-01-10 8:30 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, Head of Commercial | 2,572 | $0 | 8,409 (Direct) | View |
| 2022-04-29 Exercise | 2022-05-03 8:47 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, Head of Commercial | 1,567 | $0 | 5,004 (Direct) | View |
| 2022-04-05 Option Award | 2022-04-07 6:56 pm | N/A 2032-04-05 | ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, Head of Commercial | 89,062 | $0 | 89,062 (Direct) | View |
| 2022-02-23 Exercise | 2022-02-25 5:45 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, Head of Commercial | 1,106 | $0 | 5,743 (Direct) | View |
| 2022-01-06 Exercise | 2022-01-10 6:25 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, Head of Commercial | 1,286 | $0 | 4,361 (Direct) | View |
| 2021-11-17 Option Award | 2021-11-19 6:35 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, Head of Commercial | 79,302 | $0 | 79,302 (Direct) | View |
Ownership | 2021-11-05 4:43 pm | N/A N/A | ACADIA PHARMACEUTICALS INC | ACAD | Teehan Brendan EVP, COO, Head of Commercial | 0 | $0 | 93,208 (Direct) | View |